Agenus to Present at the JMP Securities Annual Healthcare Conference

Agenus Inc. (Nasdaq: AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be presenting at the JMP Securities 8th Annual Healthcare Conference, which will be held at the St. Regis New York. Dr. Garo Armen, Chairman and CEO of Agenus, will present a corporate overview on Tuesday, July 9th at 12:30 pm ET.

Web Cast Information

The live and archived webcast of the company presentation will be accessible from the company’s website atwww.agenusbio.com/webcast. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Agenus website for one month following the conference.

About Agenus

Agenus Inc. is a biotechnology company working to develop treatments for cancers and infectious diseases. The company is focused on immunotherapeutic products based on strong platform technologies with multiple product candidates advancing through the clinic, including several product candidates that have advanced into late-stage clinical trials through corporate partners. For more information, please visit www.agenusbio.com.

Contact:

Media and Investor Contact:
Jonae R. Barnes, 617-818-2985
Vice President
Investor Relations and Corporate Communications
jonae.barnes@agenusbio.com